Key takeaway
What This Development Means
The EU has initiated a formal re-evaluation of glyphosate’s carcinogenicity, a move that may reshape compliance duties and operational strategies across the chemical and manufacturing value chains.
Why is glyphosate’s carcinogenicity being reviewed now?
A 2025 study by the Ramazzini Institute found potential cancer risks from glyphosate exposure. Based on this new evidence, the EU is reassessing its classification to ensure regulatory decisions reflect the latest science.
Is glyphosate currently banned in the EU?
No, glyphosate is not currently banned in the EU. It remains approved for use under strict regulatory controls. However, its authorisation is subject to periodic reviews, and any new health risk findings could impact its legal status.
The European Chemicals Agency (ECHA) has been tasked by the European Commission to re-evaluate the carcinogenicity classification of glyphosate following new scientific findings. This development could significantly affect regulatory compliance and product risk assessments for professionals across the chemicals, agriculture, and manufacturing sectors.
New Evidence Spurs Review Of Glyphosate Risks
On 26 June 2025, ECHA formally requested its Committee for Risk Assessment (RAC) to reassess its 2022 opinion on glyphosate’s classification. The review follows a June 2025 study published in Environmental Health by the Ramazzini Institute, which reported potential carcinogenic effects from long-term glyphosate exposure in laboratory animals.
Glyphosate, chemically known as N-(phosphonomethyl)glycine, is a widely used herbicide (EC: 213-997-4; CAS: 1071-83-6) in agricultural, industrial, and domestic applications. The substance is currently classified in the EU as causing serious eye damage and posing chronic aquatic toxicity, but not as carcinogenic.
This reassessment could lead to regulatory reclassification, altering obligations under REACH (Regulation (EC) No 1907/2006).
Implications For Industry And Compliance
The Commission has instructed ECHA to obtain raw data from the Ramazzini Institute’s “Global Glyphosate Study,” which will underpin the new RAC evaluation. Upon receipt, RAC will have 15 months to issue an updated opinion.
Any change in glyphosate’s classification could trigger wide-reaching consequences, including reformulation of products, revised labelling, worker safety protocols, and potential market restrictions. This would affect not only chemical manufacturers but also stakeholders in agriculture, food production, and logistics.
For compliance teams, this development warrants close monitoring. A shift in classification could reframe glyphosate as a substance of very high concern (SVHC), escalating authorisation requirements and regulatory costs.
Related Articles
PFAS Pesticides Face Rising Regulatory Scrutiny Over TFA Groundwater Risks
PFAS pesticides are facing increasing regulatory scrutiny rather than uniform global restrictions. EU non-renewals, Danish withdrawals and ongoing reviews and legal actions highlight growing concern over TFA and groundwater risks. Stakeholders should monitor developments, assess exposure and prepare for evolving compliance requirements.
ClientEarth v European Commission Reinforces Transparency Rules On Mancozeb And Cypermethrin Decisions
ClientEarth v European Commission confirms that the Commission must justify refusals to disclose pesticide-related documents with specific evidence. While reinforcing transparency around mancozeb and cypermethrin decision-making, the ruling preserves important limits where disclosure could undermine court proceedings, signalling a more balanced but stricter application of EU access-to-documents rules.
Wet Gewasbeschermingsmiddelen En Biociden Ruling Triggers €1.6m Confiscation Order
Dutch court orders €1.6m profit confiscation for unauthorised plant protection product placement and forged origin documentation.
